Zions Bancorporation, N.A. Organon & Co. Transaction History

Zions Bancorporation, N.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$10.95 - $17.32 $2,890 - $4,572	-264 Reduced 92.63%	21 $0
Q3 2023 Nov 07, 2023	BUY	$16.59 - $23.77 $962 - $1,378	58 Added 25.55%	285 $4,000
Q2 2023 Jul 28, 2023	SELL	$19.27 - $24.63 $1,194 - $1,527	-62 Reduced 21.45%	227 $4,000
Q1 2023 May 10, 2023	SELL	$21.42 - $32.08 $1,906 - $2,855	-89 Reduced 23.54%	289 $6,000
Q4 2022 Feb 10, 2023	BUY	$23.31 - $28.61 $5,874 - $7,209	252 Added 200.0%	378 $10,000
Q3 2022 Nov 08, 2022	SELL	$23.4 - $34.25 $3,860 - $5,651	-165 Reduced 56.7%	126 $3,000
Q2 2022 Aug 05, 2022	BUY	$31.66 - $38.9 $1,424 - $1,750	45 Added 18.29%	291 $10,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $1,461 - $1,889	48 Added 24.24%	246 $9,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $7,970 - $10,322	-278 Reduced 58.4%	198 $7,000
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $3,922 - $4,882	-137 Reduced 22.35%	476 $16,000
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $17,439 - $23,294	613 New	613 $19,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.